Extension Notice for 2012 Credit Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Contract Categories:
Business Finance
›
Credit Agreements
Summary
Bristol-Myers Squibb Company has formally requested an extension of the maturity date for its 2012 Credit Agreement with Citibank, N.A. and other lenders. The company seeks to move the maturity date from July 30, 2018, to July 30, 2019, as permitted under the agreement. This notice serves as the official request for the extension, in accordance with the terms of the original credit facility.
EX-10.(B) 3 bmyex10bextensionnoticefor.htm EXTENSION NOTICE FOR 2012 CREDIT AGREEMENT BMY Ex 10b Extension Notice for 2012 Credit Agreement - BMS Citibank
EXHIBIT 10b.
Bristol-Myers Squibb Company
345 Park Avenue
New York, New York 10154
Citibank, N.A., as Administrative Agent
388 Greenwich Street
New York, New York 10013
Attention: Pamela Kowalski
June 2, 2014
Ladies and Gentlemen:
Re: Extension of Maturity Date
Reference is made to the Five Year Competitive Advance and Revolving Credit Facility Agreement (the “Credit Agreement”) dated as of July 30, 2012 among Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), the Borrowing Subsidiaries, the lenders parties thereto (the “Lenders”), certain Agents, Citibank, N.A., as Administrative Agent, and JPMorgan Chase Bank, N.A., as Administrative Agent. Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Credit Agreement.
Pursuant to Section 2.5 of the Credit Agreement, the Company hereby requests that the Lenders extend the Maturity Date in effect on the date hereof (i.e., July 30, 2018) to the first anniversary of such Maturity Date, such that the extended Maturity Date under the Credit Agreement will be July 30, 2019. This letter shall constitute an “Extension Letter” as referred to in Section 2.5 of the Credit Agreement.
Very truly yours, BRISTOL-MYERS SQUIBB COMPANY |
By: /s/ Jeffrey Galik Name: Jeffrey Galik Title: Senior Vice President and Treasurer |
E-10-2